Topiramate-induced psychosis: Report of two cases [2]

Expert Opinion on Drug Safety

Volumn 5, Issue 6, 2006, Pages 741-742

  Teive, Hélio A G ^a   Arruda, Walter Oleschko ^a   Munhoz, Renato P ^a   Werneck, Lineu C ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; OLANZAPINE; TOPIRAMATE;

ADOLESCENT; ADULT; AGGRESSION; ANXIETY DISORDER; BODY WEIGHT DISORDER; CASE REPORT; COMPULSION; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ECHOLALIA; EPILEPSY; HUMAN; LETTER; MALE; MENTAL DEFICIENCY; MORBID OBESITY; PARANOIA; PERSECUTORY DELUSION; PSYCHOSIS; SIDE EFFECT; THOUGHT DISORDER; VISUAL HALLUCINATION; WEIGHT GAIN;

ADOLESCENT; ADULT; FRUCTOSE; HUMANS; MALE; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 33750537806     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.5.6.741     Document Type: Letter

References (5)

1. WHITE HS, BROWN SD, WOODHEAD JH, SKEEN GA, WOLF HH: Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res. (1997) 28:167-179.
2. BEN-MENACHEM E, HENRIKSEN O, DAM M et al.: Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia (1996) 37:539-543.
3. BEGHI E: Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol. (2004) 3:618-621.
4. PERUCCA E: A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol. Res. (1997) 35:241-256.
5. KHAN A, FAUGHT E, GILLIAM F, KUZNIECKY R: Acute psychotic symptoms induced by topiramate. Seizure (1999) 8:235-237.